Steve Wigginton, CEO, Valence Health at Evolent Health, Inc. (EVH), sold 13,640 shares at $24.30 ($331K) on 2017-05-19, disclosed to the SEC on 2017-05-23.
Open-market sale of $331k EVH by CEO, Valence Health. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| EVH | SELL | 2017-06-08 | $25K | — | Filing → |
| EVH | SELL | 2017-06-05 | $145K | — | Filing → |
| EVH | SELL | 2017-05-03 | $139K | — | Filing → |